PMC3504797_01
The evolution of hemoglobin (Hb) (A), white cell count (WCC) (B), thrombocytes (C) and the DAS28 score (D) up to 19 months after therapy start. Arrows indicate time of Rituximab infusions.
TORJ-6-312_F1.jpg
PMC3504797_01_TORJ-6-312_F1.jpg
F1
An overview of the evolution of DAS and the pancytopenia in the first year of follow up is presented in Fig. (1).